Agilent Technologies IncA
Price$172.31Intrinsic value$134.6822% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $134.68median of 6 methods · middle span $123-$143based on filings through 31 Jul 2026
Market Price $172.31Price as of 30 Sep 2026
Margin of Safety -21.8%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.7% (near-term consensus, capped) · years 2–5: 10.5%/yr (balance of the path).9.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 610.3%Yr 710.1%Yr 89.9%Yr 99.7%Yr 109.6%
10.5% → 9.6%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.9%Yr 128.2%Yr 137.6%Yr 146.9%Yr 156.3%Yr 165.6%Yr 175.0%Yr 184.3%Yr 193.7%Yr 203.0%
9.6% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)14.7%
Discount rate (cost of equity) 10.1%
Volatility vs market (adjusted beta)1.15

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAgilent Technologies IncAHealth Care
Valuation
P/E34.0×
P/S6.0×
P/B6.0×
EV / Revenue6.2×
EV / EBITDA—
Profitability
Gross margin—
Operating margin22.2%
Net margin19.5%
FCF margin17.2%
Returns
ROE19.6%
ROA10.3%
ROIC15.6%
Growth
Revenue growth (YoY)13.2%
5-yr fwd EPS growth9.6%
Financial strength
Debt / Equity0.50×
Current ratio2.05×
Altman Z-Score5.6
Interest coverage—
Dividend yield0.5%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.